Table 3.
N (%) | 95% CI | |
---|---|---|
Longitudinally compare the evolution of seizure freedom between 6MSF (N = 131) vs 12MSF (N = 118) | ||
Seizure-free at 6 and 36 months | 94 (94/131, 71.8%) | 63.5–78.8 |
Seizure-free at 12 and 36 months | 94 (94/118, 79.7%) | 71.5–86.0 |
Longitudinally compare the evolution of seizure freedom between 6MNSF (N = 73) vs 12MNSF (N = 86) | ||
Not seizure-free at 6 but seizure-free at 36 months | 16 (16/73, 21.9%) | 13.9–32.8 |
Not seizure-free at 12 but seizure-free at 36 months | 19 (19/86, 22.1%) | 14.6–32.0 |
6MSF, patients who were seizure-free over the initial 6 months; 6MNSF, patients who were not seizure-free over the initial 6 months; 12MSF, patients who were seizure-free over the initial 12 months; 12MNSF, patients who were not seizure-free over the initial 12 months; CI, confidence interval.